Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Teleguided Point-of-Care Ultrasound for Fluid Assessment in Geriatric Inpatients Performed by Nurses and Medical Students: Prospective Observational Feasibility Study.

JMIR formative research·2026
Same author

[Heart failure with preserved ejection fraction in old age : Diagnostic strategies in clinical practice].

Zeitschrift fur Gerontologie und Geriatrie·2026
Same author

Immunoadsorption in dilated cardiomyopathy: the IASO-DCM trial.

European heart journal·2026
Same author

Baseline characteristics in the TransitionCHF study: asymptomatic patients with heart failure and reduced ejection fraction.

ESC heart failure·2026
Same author

Finerenone in diabetic chronic kidney disease-Real-world insights including patients with HFpEF or HFmrEF.

ESC heart failure·2025
Same author

Inferior Vena Cava Ultrasound to Guide Decongestion in Acute Decompensated Heart Failure: A Randomized Controlled Trial.

JACC. Heart failure·2025
Same journal

Impact of creatine supplementation alone or combined with exercise on inflammatory and clinical outcomes in chronic musculoskeletal pain treated in the rheumatological field: a systematic review.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same journal

Determination of the effect of simulation-based and booklet-based training on breastfeeding self-efficacy and breastfeeding problems: a randomized controlled study.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same journal

PRONTO nutritional risk identification protocol: Exploratory findings on survival prediction and comparison with the Patient-Generated Subjective Global Assessment.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same journal

Different approaches of strength-to-muscle mass ratio: impact on 24-month outcomes in patients with acute coronary syndrome.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same journal

From scriptural reference to scientific evidence a critical review of the nutritional composition and functional food potential of foods described in classical Islamic texts.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same journal

Integrating BIA-derived body composition parameters with GLIM criteria for survival prediction in patients with solid tumors.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Liver dysfunction and its nutritional implications in heart failure.

Miroslava Valentová1, Stephan von Haehling, Wolfram Doehner

  • 1Applied Cachexia Research, Department of Cardiology, Charité Medical School, Campus Virchow-Klinikum, Berlin, Germany.

Nutrition (Burbank, Los Angeles County, Calif.)
|October 2, 2012
PubMed
Summary
This summary is machine-generated.

Liver dysfunction is common in heart failure, impacting immune responses and leading to nutritional deficiencies like iron and selenium. Addressing these deficiencies through nutrition may offer new heart failure treatments.

Related Experiment Videos

Last Updated: May 18, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Area of Science:

  • Cardiology
  • Hepatology
  • Immunology

Background:

  • Heart failure frequently involves dysfunction in other organs, notably the liver, affecting up to 80% of patients.
  • The liver's roles in metabolism, endotoxin removal, immune regulation, and iron homeostasis are critical.
  • Kupffer cells, key hepatic macrophages, are central to these liver functions.

Purpose of the Study:

  • To review liver dysfunction in heart failure.
  • To elucidate the role of liver-derived factors in nutritional deficiencies in heart failure patients.
  • To explore potential nutritional interventions for heart failure.

Main Methods:

  • Literature review summarizing current knowledge on liver dysfunction in heart failure.
  • Analysis of the interplay between hepatic microcirculation, immune activation, and nutritional status.
  • Discussion of the impact of inflammation and oxidative stress on liver function.

Main Results:

  • Disturbed liver microcirculation impairs endotoxin clearance and promotes pro-inflammatory cytokine release.
  • Hepatic immune activation can alter hepcidin expression, leading to iron deficiency.
  • Pro-inflammatory states contribute to oxidative stress, potentially exacerbated by selenium deficiency in heart failure.

Conclusions:

  • Liver dysfunction is a significant, under-recognized component of heart failure pathophysiology.
  • Liver-derived factors contribute to specific nutritional deficiencies, including iron and potentially selenium.
  • Nutritional strategies targeting these deficiencies may represent a promising adjunctive therapy for heart failure.